Evolution towards small colony variants of pandemic multidrug resistant ST131 Escherichia coli isolates from a 10-year bone infection
A. Dadvar, S. Labiba, F. Li, S. Shafeeq, M. Ahl, P. Luthje, N. Dranenko, J. Trcek, A. Marzec-Grzadziel, S. K. Garushyants, H. Nagel, I. Ahmad, A. O. Schmitt, A. Diaz Lostao, V. Ozenci, M. Ullberg, M. S. Gelfand, B. Akerlund, U. Romling
Abstract
Chronic wounds are difficult to treat because underlying medical conditions can impair the mechanical and physiological first-line innate immune defenses, leading to persistent microbial infections. We report here the isolation, molecular and phenotypic characterization of seven E. coli strains that were isolated concomitantly with Enterococcus faecalis after an open foot fracture caused by the 2004 tsunami resulting in a 10-year chronic bone and joint infection. Initially present antimicrobial resistant E. coli ST405 and ST940 isolates were followed by host adapted isolates of ubiquitous ST131 clone presumably acquired from the environment already upon initial foot fracture. The E. coli ST131 clade C1 strains showed genomic alterations associated with virulence and persistence including large chromosomal inversions and, subsequently, a large deletion to cause small colony variants and higher susceptibility to formaldehyde and other stress provoking In this context deletion of hemB catalyzing an early step in the pathway for heme biosynthesis was the major, but presumably not the only cause of small colony variant emergence. Surprisingly, ST131 isolates did not display pronounced biofilm formation in conventional biofilm assays suggesting unconventional modes of persistence. In summary, the genomes of ST131 clone members are highly plastic which enables their persistence in novel ecological niches. In individuals with underlying metabolic diseases such as diabetes wound infection can prepare for colonization with ST131 E. coli isolates. FundingThis work was partially funded by ALF, the Petrus and Augusta Hedlunds Foundation and the Karolinska Institutet.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Success of Escherichia coli O25b:H4 ST131 clade C associated with a decrease in virulence
M. Duprilot, A. Baron, … M.-H. Nicolas-Chanoine·Infection and ImmunityPeer-reviewed·Nov 16, 2020
- Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones
Catherine Ludden, Arun Gonzales Decano, … Tim Downing·Microbial GenomicsPeer-reviewed·Mar 26, 2020
- Mapping the evolutionary path towards multi-drug resistance in the pandemic Escherichia coli ST131 lineage
Anna Kaarina Pöntinen, Nguyen Vinh Trung, … Jukka Corander·Microbial GenomicsPeer-reviewed·Sep 23, 2026
- Evolution of extended-spectrum β-lactamase-producing ST131 Escherichia coli at a single hospital over 15 years
Shu‐Ting Cho, Emma G. Mills, … Daria Van Tyne·Scientific ReportsPeer-reviewed·Aug 26, 2024
- Virulence potential of a multidrug-resistant Escherichia coli strain belonging to the emerging clonal group ST101-B1 isolated from bloodstream infection
A. C. d. M. S. Gheller, R. M. Silva, … T. A. T. Gomes·MicroorganismsPeer-reviewed·May 30, 2020
- Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131
Nicole Stoesser, Anna Sheppard, … Modernising Medical Microbiology Informatics Group·bioRxiv·Nov 6, 2015